CERO THERAPEUTICS HOLDINGS, INC. Investment Income, Interest
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Investment Income, Interest of $491.57 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for the quarter ending 2023-12-31 was $110.99K, a 95.52% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for the quarter ending 2023-09-30 was $121.52K, a 62.08% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for the quarter ending 2023-06-30 was $150.50K, a 305.58% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for the quarter ending 2023-03-31 was $108.56K.
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for fiscal 2023 was $491.57K, a 82.67% decline from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. investment income, interest for fiscal 2022 was $2.84M.
| Period end | Investment Income, Interest 1 month | Investment Income, Interest 3 month | Investment Income, Interest 4 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $110.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $232.51K derived: sum of 2 quarters · filed 2024-04-02 | $383.01K derived: sum of 3 quarters · filed 2024-04-02 | $491.57K 10-K · filed 2024-04-02 | ||
| 2023-09-30 | $121.52K 10-Q · filed 2023-11-09 | $272.03K derived: sum of 2 quarters · filed 2023-11-09 | $380.58K 10-Q · filed 2023-11-09 | $2.86M derived: sum of 4 quarters · filed 2024-04-02 | ||
| 2023-06-30 | $150.50K 10-Q · filed 2023-08-14 | $259.06K 10-Q · filed 2023-08-14 | $2.74M derived: sum of 3 quarters · filed 2024-04-02 | $3.06M derived: sum of 4 quarters · filed 2024-04-02 | ||
| 2023-03-31 | $108.56K 10-Q · filed 2023-05-12 | $2.59M derived: sum of 2 quarters · filed 2024-04-02 | $2.91M derived: sum of 3 quarters · filed 2024-04-02 | $2.95M derived: sum of 4 quarters · filed 2024-04-02 | ||
| 2022-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $2.80M derived: sum of 2 quarters · filed 2024-04-02 | $2.84M derived: sum of 3 quarters · filed 2024-04-02 | $2.84M 10-K · filed 2024-04-02 | ||
| 2022-09-30 | $320.48K 10-Q · filed 2023-11-09 | $357.58K derived: sum of 2 quarters · filed 2023-11-09 | $357.58K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $37.11K 10-Q · filed 2023-08-14 | $37.11K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | |||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |